Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF (ASHS)
Live price chart, market sentiment, and community perspectives for Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF (AMEX: ASHS).
Live price chart, market sentiment, and community perspectives for Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF (AMEX: ASHS).
On our desk, retail sentiment toward ASHS looks heavily polarized. While the fund boasts a striking 59.30% one-year cyclical gain, our long-term positioning is constrained by its dismal 4.22% annualized return over the past decade. It requires acute navigation of local Chinese equity sentiment rather than passive buy-and-hold confidence.
Looking at the liquidity metrics, ASHS presents severe execution friction. With an asset base sitting under $38 million and a minimal daily volume averaging around 16.1k, we observed bid-ask spreads widening out to roughly 3.97%. Risk managers must account for these hidden structural transaction costs.
From a quantitative risk perspective, ASHS recently crossed below its 200-day moving average, hovering near $41.89 down from prior peaks near $48.68. Our technical screening flags heavy downside capture, making short-term momentum signals volatile despite Morningstar awarding it a 4-star overall and 3-year rating.
Tracking the broader emerging-market equity category, market participants on our floor view ASHS as an aggressive tactical instrument rather than a core allocation. The price action dipping below the 200-day moving average multiple times between July and August 2026 signals lingering structural fragility.
Our portfolio assessment notes that ASHS carries a reasonable 0.65% expense ratio for specialized onshore small-cap exposure, tracking the CSI 500 Index. However, its ten-year rating dips down to 3 stars out of 37 funds, underlining historical consistency concerns that overshadow its recent 5-year 5-star ranking.
Our risk desk highlighted that ASHS shares traded down to a 52-week low near $29.93 before recovering toward its current range of $41 to $46. Because of the thin average volume and erratic cyclical performance, position sizing must be heavily restricted to prevent adverse fill impacts.
Explore plasma cleansing, somatic organ swaps, and BCI.